 |
Previous Article | Next Article 
The Journal of Neuroscience, April 1, 2002, 22(7):2660-2668
Metabotropic Glutamate Receptor 5 Upregulation in A-Fibers after
Spinal Nerve Injury: 2-Methyl-6-(Phenylethynyl)-Pyridine (MPEP)
Reverses the Induced Thermal Hyperalgesia
Lindsey J.
Hudson3,
Stuart
Bevan1,
Kara
McNair1,
Clive
Gentry1,
Alyson
Fox1,
Rainer
Kuhn2, and
Janet
Winter1
1 Novartis Institute for Medical Sciences, London, WC1E
6BS, United Kingdom, 2 Novartis Pharma AG, Werk
Klybeck, CH-4057 Basel, Switzerland, and 3 Oxford
GlycoSciences Ltd., Abingdon, OX14 4RY, United Kingdom
Metabotropic glutamate receptor 5 (mGluR5) protein increased
after sciatic nerve section in ipsilateral L4 and L5 DRG neuronal profiles, with most of the increase occurring in myelinated A-fiber somata. mGluR5 also increased in lamina II of the ipsilateral spinal
cord and the proximal sciatic nerve stump in this model. After L5
spinal nerve ligation, mGluR5 immunoreactivity increased dramatically
not only in damaged L5 but also in the neighboring undamaged L4.
Interestingly, after partial sciatic nerve section, mGluR5 expression
did not change in either L4 or L5 DRG neuronal profiles.
Both spinal nerve ligation and sciatic nerve partial section produced
significant mechanical and thermal hyperalgesia and tactile allodynia.
After partial sciatic nerve section, the mGluR5-specific antagonist
2-methyl-6-(phenylethynyl)-pyridine (MPEP) had no effect on any of
these behaviors. However, after L5 spinal nerve ligation, although MPEP
failed to alter the induced tactile allodynia or mechanical
hyperalgesia, it dose dependently reversed the developed thermal hyperalgesia.
Therefore, reversal of thermal hyperalgesia by MPEP correlates with
increased mGluR5 in lumbar DRG A-fiber somata after nerve injury.
Furthermore, A-fibers in the uninjured L4 DRG after L5 spinal nerve
ligation that have increased mGluR5 are the same A-fibers that newly
express vanilloid receptor 1 after such injury. Together, these results
suggest that, after L5 spinal nerve injury, mGluR5 expression on
A-fibers is essential to the development of thermal hyperalgesia. After
partial nerve section, however, it is unlikely that thermal responses
are mediated through mGluR5 because no such increase in mGluR5 is
detected in this model and MPEP is ineffective.
Key words:
MPEP; mGluR5; nerve injury; upregulation; thermal
hyperalgesia; VR1
Copyright © 2002 Society for Neuroscience 0270-6474/02/2272660-09$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
W. Guo, F. Wei, S. Zou, M. T. Robbins, S. Sugiyo, T. Ikeda, J.-C. Tu, P. F. Worley, R. Dubner, and K. Ren
Group I Metabotropic Glutamate Receptor NMDA Receptor Coupling and Signaling Cascade Mediate Spinal Dorsal Horn NMDA Receptor 2B Tyrosine Phosphorylation Associated with Inflammatory Hyperalgesia
J. Neurosci.,
October 13, 2004;
24(41):
9161 - 9173.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R.-R. Ji and G. Strichartz
Cell Signaling and the Genesis of Neuropathic Pain
Sci. Signal.,
September 28, 2004;
2004(252):
re14 - re14.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Harris, C. Joules, C. Stanley, P. Thomas, and R. W. Clarke
Glutamate and tachykinin receptors in central sensitization of withdrawal reflexes in the decerebrated rabbit
Exp Physiol,
March 1, 2004;
89(2):
187 - 198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Malherbe, N. Kratochwil, M.-T. Zenner, J. Piussi, C. Diener, C. Kratzeisen, C. Fischer, and R. H. P. Porter
Mutational Analysis and Molecular Modeling of the Binding Pocket of the Metabotropic Glutamate 5 Receptor Negative Modulator 2-Methyl-6-(phenylethynyl)-pyridine
Mol. Pharmacol.,
October 1, 2003;
64(4):
823 - 832.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Pomonis, J. E. Harrison, L. Mark, D. R. Bristol, K. J. Valenzano, and K. Walker
N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a Novel, Orally Effective Vanilloid Receptor 1 Antagonist with Analgesic Properties: II. In Vivo Characterization in Rat Models of Inflammatory and Neuropathic Pain
J. Pharmacol. Exp. Ther.,
July 1, 2003;
306(1):
387 - 393.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|